1
Cellular Energy SupportModerate
This is the whole reason NAD+ gets taken seriously at all. The biology is coherent even if the protocol outcomes are still inconsistent.
5.5/10
Weak
NAD+
NAD+ · Cellular coenzyme protocol · Longevity / Energy
The longevity clinic darling with a real biological role and a much fuzzier intervention story. Interesting, expensive, and very easy to oversell. Hype still outpaces proof.
Cost / mo
$200–800
Forms
IV + IM/SubQ
Onset
Session to weeks
Cycle
Variable
Studies
10+
Should you care about NAD+?
You should care because NAD+ is not fake science. It sits at the center of energy metabolism and repair pathways, which is exactly why longevity people can't stop talking about it.
You should stay skeptical because important biology is not the same thing as proven therapy. The commercial protocol world is much louder than the current human outcome data.
What the internet says
"NAD+ drips are basically anti-aging medicine already."
What the data says
No. They're biologically interesting, sometimes subjectively energizing, and still nowhere near settled as broad anti-aging therapy.
What it actually does (ranked by evidence)
2
Fatigue SupportWeak
Some users report a real energy lift. The problem is that the response is inconsistent and the placebo-friendly setting is obvious.
3
Longevity SignalingWeak
Great theory, limited intervention proof. This is where clinic copy gets most dramatic and least disciplined.
Dosing
Expensive wellness protocols can still be low-evidence protocols. Don't let the IV pole do the persuasion for you.
Oral
No standard oral NAD+ protocol
Most consumer use is IV, IM, or SubQ. Oral precursor products are a different conversation.
Injectable
50–750 mg/session
Huge variance across IV and injection protocols is part of the problem. Standardization is weak.
If the protocol details vary wildly from clinic to clinic, that's usually not a sign of mature evidence.
Side effects: the honest version
What the internet says
"If the infusion feels intense, it must be repairing something deep."
What the data says
It may just be a fast infusion. Acute sensation is not proof of meaningful long-term benefit.
✓ Confirmed safe
- ✓Flushing or chest tightness during fast infusions
- ✓Nausea
- ✓Injection discomfort with IM use
! Unknown
- iProtocol quality varies substantially across clinics and vendors.
- iImmediate subjective effects should not be confused with proven long-term outcomes.
- iNAD+ itself is important biology; the commercial delivery models are where the uncertainty lives.
The studies that matter
We read all 10+. These are the three we'd cite first.
Pilot human NAD+ infusion and fatigue/cognition work
WeakSmall translational studies · 2019–2024
Result: Some subjective benefit, still limited by small size and inconsistent design
Cellular NAD+ restoration and metabolic-signaling literature
ModerateAging and metabolism journals · 2010s–2020s
Result: Strong mechanistic rationale, weaker proof that clinic protocols deliver durable outcomes
Injection and infusion tolerability reports
WeakWellness-clinic and early clinical literature · 2020s
Result: Mostly tolerable, but protocol quality and interpretation remain all over the place
How it stacks up
Longevity peptide comparison. No hedging.
Score
5.5
5.2
5
Evidence
Weak
Weak
Weak
Oral?
No
Yes ✓
Yes ✓
Cost / mo
$200–800
$60–120
$40–160
Best for
Energy and longevity support
Lower-friction precursor use
Antioxidant narratives
Our pick?
Situational
Cheaper
Situational
Questions people actually ask
Answers that don't insult your intelligence.
No. It is not a peptide in the strict biochemical sense, but it often appears in the same consumer market and protocol discussions.
★ Bottom Line
NAD+ is important biology wrapped in a much shakier consumer story. The molecule is real. The clinic marketing often reads like it forgot evidence still matters.
— PepTalk Editorial Team · March 2026